Identification of Immunological Characteristics and Immune Subtypes Based on Single-Sample Gene Set Enrichment Analysis Algorithm in Lower-Grade Glioma

Identification of Immunological Characteristics and Immune Subtypes Based on Single-Sample Gene Set Enrichment Analysis Algorithm in Lower-Grade Glioma

Few breakthroughs have been achieved in the treatment of lower-grade glioma (LGG) in recent decades. Apart from the conventional pathological and histological classifications, subtypes based on immunogenomics would provide reference for individualized treatment and prognosis prediction. Our study id...

Full description

Bibliographic Details
Main Authors:	Yunyang Zhu, Songwei Feng, Zhaoming Song, Zhong Wang, Gang Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Genetics
Subjects:	lower-grade glioma immunogenomics immune clusters glioma tumor-immune microenvironment
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.894865/full

Similar Items

Immunological classification of gliomas based on immunogenomic profiling
by: Qiushi Feng, et al.
Published: (2020-11-01)

Classification of diffuse lower‐grade glioma based on immunological profiling
by: Fan Wu, et al.
Published: (2020-09-01)

Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis
by: Binghao Zhao, et al.
Published: (2021-06-01)

A Prediction Model for Deciphering Intratumoral Heterogeneity Derived from the Microglia/Macrophages of Glioma Using Non-Invasive Radiogenomics
by: Yunyang Zhu, et al.
Published: (2023-12-01)

ZNF480 influences the prognosis, pathogenesis, and immune microenvironment in patients with lower-grade glioma
by: Qingyun Zhu, et al.
Published: (2023-07-01)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
by: Hongbo Zhang, et al.
Published: (2020-12-01)

Heterogeneity in clinical prognosis, immune infiltration and molecular characteristics of three glycolytic subtypes in lower-grade gliomas
by: Shenglian Wu, et al.
Published: (2023-05-01)

A Novel Six Autophagy-Related Genes Signature Associated With Outcomes and Immune Microenvironment in Lower-Grade Glioma
by: Tao Lin, et al.
Published: (2021-10-01)

Identification and validation of a risk model and molecular subtypes based on tryptophan metabolism-related genes to predict the clinical prognosis and tumor immune microenvironment in lower-grade glioma
by: Wenxia Li, et al.
Published: (2023-02-01)

The integrative analysis based on super-enhancer related genes for predicting different subtypes and prognosis of patient with lower-grade glioma
by: Yungang Hu, et al.
Published: (2023-04-01)

Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas
by: Liguo Ye, et al.
Published: (2021-10-01)

Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma
by: Shengchao Xu, et al.
Published: (2021-09-01)

Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma
by: Xiaoshuai Ji, et al.
Published: (2020-10-01)

Glycosylation modification patterns reveal distinct tumor metabolism and immune microenvironment landscape in lower-grade gliomas
by: Guihua Tang, et al.
Published: (2022-08-01)

Comprehensive analysis of the clinical and biological significances of cholesterol metabolism in lower-grade gliomas
by: Rui Tao, et al.
Published: (2023-07-01)

Identification of molecular subtypes based on inflammatory response in lower-grade glioma
by: Wanzun Lin, et al.
Published: (2022-10-01)

Comparative profiling of immune genes improves the prognoses of lower grade gliomas
by: Zhiliang Wang, et al.
Published: (2022-04-01)

Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma
by: Huaide Qiu, et al.
Published: (2021-04-01)

The Prognostic and Immunological Value of Guanylate-Binding Proteins in Lower-Grade Glioma: Potential Markers or Not?
by: Zhuang Liu, et al.
Published: (2021-10-01)

Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma
by: Huihan Yu, et al.
Published: (2022-08-01)

Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas
by: Jia-hao Bao, et al.
Published: (2022-08-01)

Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas
by: Wei Huang, et al.
Published: (2023-02-01)

Integrated analysis of necroptosis related gene signature to predict clinical outcomes, immune status and drug sensitivity in lower grade Glioma
by: Xiqi Hu, et al.
Published: (2024-01-01)

Staged resection of multilobar lower-grade glioma: Case report and review of the literature
by: Ronald Sahyouni, et al.
Published: (2022-06-01)

Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma
by: Li Xiao-min, et al.
Published: (2023-10-01)

Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma
by: Shenbin Xu, et al.
Published: (2021-09-01)

Comprehensive analysis of the prognostic and role in immune cell infiltration of MSR1 expression in lower‐grade gliomas
by: Qiankun Ji, et al.
Published: (2022-05-01)

Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma
by: Yudong Cao, et al.
Published: (2022-08-01)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
by: Mingwei Zhang, et al.
Published: (2020-04-01)

Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas
by: Yirui Kuang, et al.
Published: (2023-04-01)

Expression and clinical significance of RBBP4 gene in lower-grade glioma: An integrative analysis
by: Ruofei Liang, et al.
Published: (2023-09-01)

Prognostic value of γ‐aminobutyric acidergic synapse-associated signature for lower-grade gliomas
by: Hongxiang Jiang, et al.
Published: (2022-11-01)

PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma
by: Wenqian Zhi, et al.
Published: (2023-09-01)

Liquid biopsy-based identification of prognostic and immunotherapeutically relevant gene signatures in lower grade glioma
by: Changwu Wu, et al.
Published: (2023-02-01)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
by: Xiangyang Deng, et al.
Published: (2019-11-01)

Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma
by: Yao Zhou, et al.
Published: (2023-12-01)

PD-L2 Serves as a Potential Prognostic Biomarker That Correlates With Immune Infiltration and May Predict Therapeutic Sensitivity in Lower-Grade Gliomas
by: Qijun Xie, et al.
Published: (2022-06-01)

Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma
by: Junsheng Zhao, et al.
Published: (2021-11-01)

A Bioinformatics-Based Analysis of an Anoikis-Related Gene Signature Predicts the Prognosis of Patients with Low-Grade Gliomas
by: Songyun Zhao, et al.
Published: (2022-10-01)

Low-Grade Gliomas: Histological Subtypes, Molecular Mechanisms, and Treatment Strategies
by: Corneliu Toader, et al.
Published: (2023-12-01)